×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
JSPR – jasper therapeutics, inc. - class a (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
JSPR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/16
09:56 am
jspr
We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate [Yahoo! Finance]
Medium
Report
We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate [Yahoo! Finance]
11/16
01:39 am
jspr
Is Jasper Therapeutics (JSPR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
Medium
Report
Is Jasper Therapeutics (JSPR) the Best Multibagger Stock to Buy Heading into 2025? [Yahoo! Finance]
11/13
04:30 pm
jspr
Jasper Therapeutics to Participate at Upcoming Investor Conferences
Medium
Report
Jasper Therapeutics to Participate at Upcoming Investor Conferences
11/7
07:30 am
jspr
Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
Jasper Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/24
08:08 am
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $65.00 price target on the stock.
10/24
08:00 am
jspr
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
Medium
Report
Jasper Therapeutics to Present Preclinical Briquilimab Data at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting
10/23
08:00 am
jspr
Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
Low
Report
Jasper Therapeutics Announces Further Expansion of Clinical Program in Chronic Spontaneous Urticaria
10/15
12:31 pm
jspr
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $70.00 price target on the stock.
Low
Report
Jasper Therapeutics, Inc. (NASDAQ: JSPR) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $70.00 price target on the stock.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
06:02 pm
jspr
Form SC 13G/A Jasper Therapeutics, Filed by: Avidity Partners Management LP
Medium
Report
Form SC 13G/A Jasper Therapeutics, Filed by: Avidity Partners Management LP
11/14
03:33 pm
jspr
Form SC 13G/A Jasper Therapeutics, Filed by: Soleus Private Equity Fund III, L.P.
Low
Report
Form SC 13G/A Jasper Therapeutics, Filed by: Soleus Private Equity Fund III, L.P.
11/8
02:22 pm
jspr
Form SC 13G Jasper Therapeutics, Filed by: BlackRock, Inc.
Medium
Report
Form SC 13G Jasper Therapeutics, Filed by: BlackRock, Inc.
11/7
07:43 am
jspr
Form 8-K Jasper Therapeutics, For: Nov 07
Medium
Report
Form 8-K Jasper Therapeutics, For: Nov 07
11/7
07:31 am
jspr
Form 10-Q Jasper Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Jasper Therapeutics, For: Sep 30
11/4
12:06 pm
jspr
Form SC 13G/A Jasper Therapeutics, Filed by: SPHERA FUNDS MANAGEMENT LTD.
Low
Report
Form SC 13G/A Jasper Therapeutics, Filed by: SPHERA FUNDS MANAGEMENT LTD.
10/22
06:08 pm
jspr
Form SC 13G Jasper Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Jasper Therapeutics, Filed by: BlackRock, Inc.
10/15
06:12 am
jspr
Form 8-K Jasper Therapeutics, For: Oct 14
Medium
Report
Form 8-K Jasper Therapeutics, For: Oct 14
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: